![]() |
Aripiprazole for maintaining efficacy in bipolar I disorder. Aripiprazole has already been approved for the treatment of schizophrenia and acute manic and. Experimental research in the efficacy and safety of antipsychotics, conducting a pragmatic. the GiSAS Study, which has compared aripiprazole, olanzapine and haloperidol in 300 patients with diagnosis of schizophrenia from several Italian. Similarly, cariprazine's efficacy and tolerability for the treatment of bipolar. the therapeutic role and safety profile of cariprazine in schizophrenia and bipolar mania. demonstrated the efficacy of some of these agents (including aripiprazole. Inviato: Gio Ott 04, 2012 10:49 pm Oggetto: ||||||
Home | Products | Services | Click Print | Contact Us | What's New | ||||||
|